Skip to main navigation Skip to search Skip to main content

Susceptibility of Clinical Gram-Positive Isolates from Cancer Patients to Daptomycin

Project: Research

Project Details

StatusFinished
Effective start/end date06/24/02 → 06/23/07

Funding

  • Cubist Pharmaceuticals: $34,070.00